Effects of the CRH receptor antagonist CP-154,526 on intravenous cocaine self-administration in rats

Neuropsychopharmacology

Volumn 23, Issue 5, 2000, Pages 577-586

  Goeders, Nick E ^a   Guerin, Glenn F ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Cocaine; Corticotropin releasing hormone; Rat; Reinforcement; Self administration

Indexed keywords

BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; COCAINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; COCAINE DEPENDENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SELF ADMINISTRATION; MALE; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ANIMAL; COCAINE; COCAINE-RELATED DISORDERS; CONDITIONING, OPERANT; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FOOD; MALE; PYRIMIDINES; PYRROLES; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0033802193     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00148-2     Document Type: Article

References (50)

1. Ambrosio E., Sharpe L.G., Pilotte N.S. Regional binding to corticotropin releasing factor receptors in brain of rats exposed to chronic cocaine and cocaine withdrawal. Synapse. 26:1997;272-276.
2. Baker D.A., Fuchs R.A., Tran-Nguyen L.T., Palmer A.J., Marshall J.F., McPherson R.J., Neisewander J.L. Cocaine-seeking behavior and Fos expression in the amygdala produced by cocaine or a cocaine self-administration environment. Ann NY Acad Sci. 877:1999;796-799.
3. Baumann M.H., Gendron T.M., Becketts K.M., Henningfield J.E., Gorelick D.A., Rothman R.B. Effects of intravenous cocaine on plasma cortisol and prolactin in human cocaine abusers. Biol Psychiatry. 38:1995;751-755.
4. Britton D.R., Hoffman D.K., Lederis K., Rivier J. A comparison of the behavioral effects of CRF, sauvagine and urotensin I. Brain Res. 304:1984;201-205.
5. Borowsky B., Kuhn C.M. Monoamine mediation of cocaine-induced hypothalamo-pituitary-adrenal activation. J Pharmacol Exp Ther. 256:1991;204-210.
6. Cador M., Cole B.J., Koob G.F., Stinus L., Le Moal M. Central administration of corticotropin-releasing factor induces long-term sensitization to D-amphetamine. Brain Res. 606:1993;181-186.
7. Caine S.B., Heinrichs S.C., Coffin V.L., Koob G.F. Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Res. 692:1995;47-56.
8. Cole B.J., Koob G.F. Low doses of corticotropin-releasing factor potentiate amphetamine-induced stereotyped behavior. Psychopharmacology. 99:1989;27-33.
9. Cole B.J., Cador M., Stinus L., Rivier J., Vale W., Koob G.F., Le Moal M. Central administration of a CRF antagonist blocks the development of stress-induced behavioral sensitization. Brain Res. 512:1990;343-346.
10. Deminiére J.M., Taghzouti K., Tassin J.P., Le Moal M., Simon H. Increased sensitivity to amphetamine and facilitation of amphetamine self-administration after 6-hydroxydopamine lesions of the amygdala. Psychopharmacology. 94:1988;232-236.
11. De Vries A.C., Pert A. Conditioned increases in anxiogenic-like behavior following exposure to contextual stimuli associated with cocaine are mediated by corticotropin-releasing factor. Psychopharmacology. 137:1998;333-340.
12. De Vries A.C., Taymans S.E., Sundstrom J.M., Pert A. Conditioned release of corticosterone by contextual stimuli associated with cocaine is mediated by corticotropin-releasing factor. Brain Res. 786:1998;39-46.
13. Dunn A.J., Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration. is CRF a mediator of anxiety or stress responses? Brain Res Rev. 15:1990;71-100.
14. Erb S., Shaham Y., Stewart J. The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J Neurosci. 18:1998;5529-5536.
15. Gardi J., Biro E., Sarnyai Z., Vecsernyes M., Julesz J., Telegdy G. Time-dependent alterations in corticotropin-releasing factor-like immunoreactivity in different brain regions after acute cocaine administration to rats. Neuropeptides. 31:1997;15-18.
16. Goeders N.E., Smith J.E. Cortical dopaminergic involvement in cocaine reinforcement. Science. 221:1983;773-775.
17. Goeders N.E., Bienvenu O.J., De Souza E.B. Chronic cocaine administration alters corticotropin-releasing factor receptors in the rat brain. Brain Res. 531:1990;322-328.
18. Goeders N.E., Smith J.E. Intracranial cocaine self-administration into the medial prefrontal cortex increases dopamine turnover in the nucleus accumbens. J Pharmacol Exp Ther. 265:1993;592-600.
19. Goeders N.E., Guerin G.F. Role for corticosterone in intravenous cocaine self-administration in rats. Neuroendocrinology. 64:1996;337-348.
20. Goeders N.E. A neuroendocrine role in cocaine reinforcement. Psychoneuroendocrinology. 22:1997;237-259.
21. Goeders N.E., Peltier R.L., Guerin G.F. Ketoconazole reduces low dose cocaine self-administration in rats. Drug Alcohol Dependence. 53:1998;67-77.
22. Goeders N.E., Clampitt D., Peltier R.L., Guerin G.F. Reinstatement of cocaine-seeking behavior using a conditioned reinforcer. Role for the hypothalamo-pituitary-adrenal (HPA) axis Harris L.S. NIDA Research Monograph, Problems of Drug Dependence, 1999, NIH Publication 00-4737. 2000;NIH, p 92, Bethesda, MD.
23. Hurd Y.L., McGregor A., Ponten M. In vivo amygdala dopamine levels modulate cocaine self-administration behaviour in the rat. D1 dopamine receptor involvement Eur J Neurosci. 9:1997;2541-2548.
24. Kalivas P.W., Duffy P., Latimer G. Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat. J Pharmacol Exp Ther. 242:1987;757-763.
25. Koob G.F., Goeders N.E. Neuroanatomical substrates of drug self-administration. Liebman J.M., Cooper S.J. Oxford Reviews in Psychopharmacology, Vol. 1, Neuropharmacological Basis of Reward. 1989;214-263 Oxford University Press, London.
26. Koob G.F., Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science. 242:1988;715-723.
27. Mansbach R.S., Brooks E.N., Chen Y.L. Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist. Eur J Pharmacol. 323:1997;21-26.
28. Mantsch J.R., Goeders N.E. Ketoconazole blocks the stressor-induced reinstatement of cocaine-seeking behavior in rats. relationship to the discriminative stimulus effects of cocaine Psychopharmacology. 142:1999;399-407.
29. McCarthy J.R., Heinrichs S.C., Grigoriadis D.E. Recent advances with the CRF1 receptor. design of small molecule inhibitors, receptor subtypes and clinical implications Cur Pharmacol Design. 5:1999;289-315.
30. Meil W.M., See R.E. Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from self-administered cocaine. Behav Brain Res. 87:1997;139-148.
31. Mendelson J.H., Mello N.K., Teoh S.K., Ellingboe J., Cochin J. Cocaine effects on the pulsatile secretion of anterior pituitary, gonadal, and adrenal hormones. J Clin Endocrinol Metab. 69:1989;1256-1260.
32. Moldow R.L., Fischman A.J. Cocaine induced secretion of ACTH, beta-endorphin, and corticosterone. Peptides. 8:1987;819-822.
33. Peltier RL, Guerin GF, Dorairaj NR, Irby BD, Goeders NE (1999): The effect of saline substitution tests on plasma corticosterone in rats trained to self-administer cocaine. In Harris LS (ed), NIDA Research Monograph, Problems of Drug Dependence, 1998. NIH publication 99-4395. Bethesda, MD, NIH, p 254.
34. Piazza P.V., Rougé-Pont F., Deminiére J.M., Kharoubi M., Le Moal M., Simon H. Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration. Brain Res. 567:1991;169-174.
35. Richter R.M., Merlo Pich E., Koob G.F., Weiss F. Sensitization of cocaine-stimulated increase in extracellular levels of corticotropin-releasing factor from the rat amygdala after repeated administration as determined by intracranial microdialysis. Neurosci Lett. 187:1995;169-172.
36. Richter R.M., Weiss F. In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats. Synapse. 32:1999;254-261.
37. Rivier C.L., Vale W. Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism. Brain Res. 422:1987;403-406.
38. Rivier C., Lee S. Stimulatory effects of cocaine on ACTH secretion. role of the hypothalamus Mol Cell Neurosci. 5:1994;189-195.
39. Sarnyai Z., Biro E., Penke B., Telegdy G. The cocaine-induced elevation of plasma corticosterone is mediated by endogenous corticotropin-releasing factor (CRF) in rats. Brain Res. 589:1992;154-156. a.
40. Sarnyai Z., Hohn J., Szabo G., Penke B. Critical role of endogenous corticotropin-releasing factor (CRF) in the mediation of the behavioral action of cocaine in rats. Life Sci. 51:1992;2019-2024. b.
41. Sarnyai Z., Biro E., Gardi J., Vecsernyes M., Julesz J., Telegdy G. Alterations of corticotropin-releasing factor-like immunoreactivity in different brain regions after acute cocaine administration in rats. Brain Res. 616:1993;315-319.
42. Sarnyai Z., Mello N.K., Mendelson J.H., Eros-Sarnyai M., Mercer G. Effects of cocaine on pulsatile activity of the hypothalamic-pituitary-adrenal axis in male rhesus monkeys. neuroendocrine and behavioral correlates J Pharmacol Exp Ther. 277:1996;225-234.
43. Schulz D.W., Mansbach R.S., Sprouse J., Braselton J.P., Collins J., Corman M., Dunaiskis A., Faraci S., Schmidt A.W., Seeger T., Seymour P., Tingley F.D., Winston E.N., Chen Y.L., Heym J. CP-154,526. a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors Proc Natl Acad Sci USA. 93:1996;10477-10482.
44. Shaham Y., Funk D., Brown T.J., Walker C.-D., Stewart J. Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci. 17:1997;2605-2614.
45. 1 receptor attenuates stress-induced relapse to drug-seeking behavior in cocaine- and heroin-trained rats. Psychopharmacology. 137:1998;184-190.
46. Teoh S.K., Sarnyai Z., Mendelson J.H., Mello N.K., Springer S.A., Sholar J.W., Wapler M., Kuehnle J.C., Gelles H. Cocaine effects on pulsatile secretion of ACTH in men. J Pharmacol Exp Ther. 270:1994;1134-1138.
47. Weiss S.R., Nierenberg J., Lewis R., Post R.M. Corticotropin-releasing hormone. potentiation of cocaine-kindled seizures and lethality Epilepsia. 33:1992;248-254.
48. Whitelaw R.B., Markou A., Robbins T.W., Everitt B.J. Excitotoxic lesions of the basolateral amygdala impair the acquisition of cocaine-seeking behaviour under a second-order schedule of reinforcement. Psychopharmacology. 127:1996;213-224.
49. Yang X.M., Gorman A.L., Dunn A.J., Goeders N.E. Anxiogenic effects of acute and chronic cocaine administration. neurochemical and behavioral studies Pharmacol Biochem Behav. 41:1992;643-650.
50. Zhou Y., Spangler R., LaForge K.S., Maggos C.E., Ho A., Kreek M.J. Corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and withdrawal. J Pharmacol Exp Ther. 279:1996;351-358.